Trials / Conditions / Raynaud's Phenomenon

Raynaud's Phenomenon

10 registered clinical trials studyying Raynaud's Phenomenon.

Status	Trial	Sponsor	Phase
Completed	The Effects of Exercise in Patients With Systemic Sclerosis NCT03058887	Sheffield Hallam University	N/A
Completed	Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon NCT02583789	Brigham and Women's Hospital	EARLY_Phase 1
Completed	A Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP) NCT02506062	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	N/A
Completed	"As Required" Oral Sildenafil in Raynaud's Phenomenon NCT02050360	University Hospital, Grenoble	Phase 2 / Phase 3
Unknown	Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers o NCT01378845	Christoph Hehrlein	N/A
Terminated	Efficacy of ORM-12741 for Prevention of Raynaud's Phenomenon NCT01315899	Orion Corporation, Orion Pharma	Phase 2
Completed	A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma NCT01117298	Sanjay Gandhi Postgraduate Institute of Medical Sciences	Phase 3
Completed	MQX-503 Applied to the Hand Versus Nitroglycerin Ointment Applied to the Chest: A Pharmacokinetic Comparison NCT00841594	MediQuest Therapeutics	Phase 1
Completed	Dose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's Phenomenon NCT00700518	Procris Pharmaceuticals	Phase 1
Completed	The Effect of Physical Therapy on Raynaud's Phenomenon Secondary to Systemic Sclerosis NCT00946738	Charite University, Berlin, Germany	N/A